The latest issue of Weill Cornell Medicine, the magazine of Weill Cornell Medical College and Weill Cornell Graduate School of Medical Science, profiled the lymphoma program and the improvements in treatment and better outcomes being developed by our physicians and researchers on behalf of our lymphoma patients. If you turn to page 30 of the reader you can find the full article.
Tag: leukemia treatment
Dr. Richard Furman Discusses Emerging Strategies for the Treatment of CLL & Follicular Lymphoma
In this video from Onc Live, Dr. Richard Furman, Director of the CLL Research Center discusses emerging strategies in the treatment of CLL and follicular lymphoma, specifically citing the use of venetoclax also known as ABT-199.
For patients with CLL the following trials are open to accrual.
Dr. Richard Furman Discusses Recent Changes in CLL Treatment
In this video clip from OncLive, Director of the CLL Research Center, Richard R. Furman, M.D. discusses the new treatments that have changed the care for patients with chronic lymphocytic leukemia (CLL).
New Developments in Lymphoma 